ViaDerma (VDRM) Stock Chart & Stock Price History $0.0001 0.00 (0.00%) As of 10/17/2025 11:13 AM Eastern Add Compare Share Share Chart Stock AnalysisChartShort InterestBuy This Stock ViaDerma Stock Price Performance The ViaDerma (VDRM) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has decreased 98.00%, with a year-to-date return of -98.65%. In the past month, the stock has decreased 50.00%, reflecting recent market activity. As of the latest close, ViaDerma traded at $0.00 with a market cap of and volume of 1,189 shares. Receive VDRM Stock News and Ratings via EmailSign-up to receive the latest news and ratings for ViaDerma and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. 1 Month Performance-50.00%3 Month Performance-80.00%Year-To-Date Performance-98.65%1 Year Performance-98.00% VDRM Stock Chart for Saturday, October, 18, 2025 VDRM Chart by TradingView ViaDerma Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization10/17/2025$0.00$0.00$0.00$0.001,189 shs$0.0010/16/2025N/A$0.00$0.00$0.00100,000 shs$0.0010/10/2025$0.00$0.00$0.00$0.0020,000 shs$0.0010/09/2025$0.00$0.00$0.00$0.0020,000 shs$0.0010/08/2025$0.00$0.00-50.00%$0.00$0.0049,019 shs$0.0010/07/2025$0.00$0.00$0.00$0.0040 shs$0.0010/06/2025$0.00$0.00$0.00$0.0040 shs$0.0010/03/2025$0.00$0.00$0.00$0.004,377 shs$0.0010/02/2025$0.00$0.00$0.00$0.004,377 shs$0.0010/01/2025$0.00$0.00$0.00$0.003,082 shs$0.00 Get the Latest News and Ratings for VDRM and Related StocksEnter your email address below to receive the latest news and analysts' ratings for ViaDerma and its competitors with MarketBeat's FREE daily newsletter. 09/30/2025$0.00$0.00$0.00$0.003,082 shs$0.0009/29/2025$0.00$0.00$0.00$0.0020,100 shs$0.0009/26/2025$0.00$0.00$0.00$0.006,666 shs$0.0009/25/2025$0.00$0.00+100.00%$0.00$0.00105,000 shs$0.0009/24/2025$0.00$0.00$0.00$0.0010,500 shs$0.0009/23/2025$0.00$0.00-50.00%$0.00$0.0010,500 shs$0.0009/22/2025$0.00$0.00$0.00$0.00900 shs$0.0009/19/2025$0.00$0.00$0.00$0.00900 shs$0.0009/18/2025$0.00$0.00$0.00$0.0016,000 shs$0.0009/17/2025$0.00$0.00$0.00$0.0020,000 shs$0.00 Related Companies 180 Life Sciences Stock Price Chart 4D pharma Stock Price Chart 4Front Ventures Stock Price Chart Abattis Bioceuticals Stock Price Chart Abcam Stock Price Chart Acusphere Stock Price Chart Adhera Therapeutics Stock Price Chart Aeolus Pharmaceuticals Stock Price Chart Agentix Stock Price Chart Ainos Stock Price Chart Receive VDRM Stock News and Ratings via EmailSign-up to receive the latest news and ratings for ViaDerma and its competitors with MarketBeat's FREE daily newsletter. This page (OTCMKTS:VDRM) was last updated on 10/18/2025 by MarketBeat.com Staff From Our PartnersHoly ****... This could actually MAGAA new document circulating from Washington is stirring major controversy — one that some say could redefine Am...StocksToTrade | SponsoredNvidia CEO Makes First Ever Tesla AnnouncementWhile headlines focus on Tesla’s car sales, tech analyst Jeff Brown says the real story is Tesla’s role in a $...Brownstone Research | SponsoredMove $1,000 into this stock before Nov 6The End of Tesla? "Hold onto your Tesla stock." That's the message insiders at Tesla have been giving staff...Altimetry | SponsoredThe $20 stock that could make silicon chips obsolete$2 TRILLION Quantum Gold Rush While everyone fights over expensive AI stocks... McKinsey just revealed the ...The Oxford Club | SponsoredREVEALED: Something Big Happening Behind White House DoorsWhat I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | SponsoredTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredNEW LAW: Congress Approves Setup For Digital Dollar?Trump Ally Says Congress Approved the Setup for a Digital Dollar 2.0 But according to Rep. Marjorie Taylor ...Goldco Precious Metals | SponsoredTrump Devises the Death of the IRS ☠️Trump has just signed an executive order creating America's first-ever National Investment Fund — a game-chang...Angel Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ViaDerma, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share ViaDerma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
